Forma raises $25.5 million

Forma Therapeutics Inc. (Cambridge, Mass.) raised $25.5 million in a series B round led by new investor Lilly Ventures. Existing investors Novartis Option Fund and Bio*One Capital also participated. Partner Cubist Pharmaceuticals Inc. (NASDAQ:CBST) also joined as a new equity investor through the conversion of a note issued under a January antibacterial deal (See BioCentury, Jan. 26, 2009). ...